QQQ   292.95 (+0.88%)
AAPL   114.43 (+0.51%)
MSFT   212.66 (+1.21%)
FB   274.09 (+2.11%)
GOOGL   1,753.61 (+1.51%)
AMZN   3,111.74 (+0.43%)
TSLA   543.13 (+4.08%)
NVDA   516.59 (-1.71%)
BABA   276.25 (+2.27%)
CGC   26.50 (+7.20%)
GE   10.62 (+5.46%)
MU   63.42 (-1.18%)
AMD   84.54 (-0.90%)
T   29.37 (+2.62%)
NIO   53.16 (-4.01%)
F   9.40 (+6.09%)
ACB   8.82 (+22.84%)
NFLX   480.62 (+0.84%)
GILD   60.83 (+1.57%)
BA   220.29 (+4.14%)
DIS   150.48 (+3.08%)
QQQ   292.95 (+0.88%)
AAPL   114.43 (+0.51%)
MSFT   212.66 (+1.21%)
FB   274.09 (+2.11%)
GOOGL   1,753.61 (+1.51%)
AMZN   3,111.74 (+0.43%)
TSLA   543.13 (+4.08%)
NVDA   516.59 (-1.71%)
BABA   276.25 (+2.27%)
CGC   26.50 (+7.20%)
GE   10.62 (+5.46%)
MU   63.42 (-1.18%)
AMD   84.54 (-0.90%)
T   29.37 (+2.62%)
NIO   53.16 (-4.01%)
F   9.40 (+6.09%)
ACB   8.82 (+22.84%)
NFLX   480.62 (+0.84%)
GILD   60.83 (+1.57%)
BA   220.29 (+4.14%)
DIS   150.48 (+3.08%)
QQQ   292.95 (+0.88%)
AAPL   114.43 (+0.51%)
MSFT   212.66 (+1.21%)
FB   274.09 (+2.11%)
GOOGL   1,753.61 (+1.51%)
AMZN   3,111.74 (+0.43%)
TSLA   543.13 (+4.08%)
NVDA   516.59 (-1.71%)
BABA   276.25 (+2.27%)
CGC   26.50 (+7.20%)
GE   10.62 (+5.46%)
MU   63.42 (-1.18%)
AMD   84.54 (-0.90%)
T   29.37 (+2.62%)
NIO   53.16 (-4.01%)
F   9.40 (+6.09%)
ACB   8.82 (+22.84%)
NFLX   480.62 (+0.84%)
GILD   60.83 (+1.57%)
BA   220.29 (+4.14%)
DIS   150.48 (+3.08%)
QQQ   292.95 (+0.88%)
AAPL   114.43 (+0.51%)
MSFT   212.66 (+1.21%)
FB   274.09 (+2.11%)
GOOGL   1,753.61 (+1.51%)
AMZN   3,111.74 (+0.43%)
TSLA   543.13 (+4.08%)
NVDA   516.59 (-1.71%)
BABA   276.25 (+2.27%)
CGC   26.50 (+7.20%)
GE   10.62 (+5.46%)
MU   63.42 (-1.18%)
AMD   84.54 (-0.90%)
T   29.37 (+2.62%)
NIO   53.16 (-4.01%)
F   9.40 (+6.09%)
ACB   8.82 (+22.84%)
NFLX   480.62 (+0.84%)
GILD   60.83 (+1.57%)
BA   220.29 (+4.14%)
DIS   150.48 (+3.08%)
Log in
NASDAQ:CNMD

CONMED Stock Forecast, Price & News

$105.97
+2.65 (+2.56 %)
(As of 11/24/2020 12:00 PM ET)
Add
Compare
Today's Range
$104.09
Now: $105.97
$106.30
50-Day Range
$77.70
MA: $86.49
$101.23
52-Week Range
$37.66
Now: $105.97
$116.81
Volume5,130 shs
Average Volume363,324 shs
Market Capitalization$3.03 billion
P/E Ratio111.55
Dividend Yield0.79%
Beta0.56
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; and endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.
Read More
CONMED logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.50 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:CNMD
CUSIP20741010
Phone315-797-8375
Employees3,300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$955.10 million
Cash Flow$4.63 per share
Book Value$23.54 per share

Profitability

Net Income$28.62 million

Miscellaneous

Market Cap$3.03 billion
Next Earnings Date2/3/2021 (Estimated)
OptionableOptionable
$105.97
+2.65 (+2.56 %)
(As of 11/24/2020 12:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CNMD News and Ratings via Email

Sign-up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CONMED (NASDAQ:CNMD) Frequently Asked Questions

How has CONMED's stock price been impacted by COVID-19 (Coronavirus)?

CONMED's stock was trading at $78.77 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CNMD stock has increased by 34.5% and is now trading at $105.97.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of CONMED?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for CONMED
.

What stocks does MarketBeat like better than CONMED?

Wall Street analysts have given CONMED a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CONMED wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is CONMED's next earnings date?

CONMED is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for CONMED
.

How were CONMED's earnings last quarter?

CONMED Co. (NASDAQ:CNMD) issued its quarterly earnings results on Wednesday, October, 28th. The medical technology company reported $0.88 EPS for the quarter, beating the consensus estimate of $0.25 by $0.63. CONMED had a return on equity of 11.18% and a net margin of 3.00%.
View CONMED's earnings history
.

How often does CONMED pay dividends? What is the dividend yield for CONMED?

CONMED declared a quarterly dividend on Tuesday, November 17th. Shareholders of record on Tuesday, December 15th will be given a dividend of $0.20 per share on Tuesday, January 5th. This represents a $0.80 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date is Monday, December 14th.
View CONMED's dividend history
.

What price target have analysts set for CNMD?

6 brokerages have issued 1 year target prices for CONMED's shares. Their forecasts range from $76.00 to $110.00. On average, they anticipate CONMED's stock price to reach $94.60 in the next year. This suggests that the stock has a possible downside of 10.7%.
View analysts' price targets for CONMED
.

Who are some of CONMED's key competitors?

What other stocks do shareholders of CONMED own?

Who are CONMED's key executives?

CONMED's management team includes the following people:
  • Mr. Curt R. Hartman, Chairman, CEO & Pres (Age 56, Pay $2.04M)
  • Mr. Todd W. Garner, Exec. VP & CFO (Age 51, Pay $941.04k)
  • Mr. Patrick J. Beyer, Pres of International & Global Orthopedics (Age 54, Pay $927.34k)
  • Mr. Stanley W. Peters III, VP & GM of U.S. Advanced Surgical (Age 45, Pay $858.66k)
  • Mr. Nathan Folkert, VP & GM of U.S. Orthopedics (Age 45, Pay $626.98k)

What is CONMED's stock symbol?

CONMED trades on the NASDAQ under the ticker symbol "CNMD."

Who are CONMED's major shareholders?

CONMED's stock is owned by a variety of retail and institutional investors. Top institutional investors include Champlain Investment Partners LLC (5.48%), Earnest Partners LLC (3.90%), Principal Financial Group Inc. (3.55%), State Street Corp (3.31%), Point72 Asset Management L.P. (2.96%) and AXA S.A. (2.37%). Company insiders that own CONMED stock include Brian Concannon, Daniel Jonas, Dirk Kuyper, John Jed Kennedy, John L Workman, Johonna Marie Pelletier, Peter K Shagory, Stanley W Peters III, Terence M Berge and Wilfredo Ruiz-Caban.
View institutional ownership trends for CONMED
.

Which institutional investors are selling CONMED stock?

CNMD stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, Jefferies Group LLC, Point72 Asset Management L.P., Acadian Asset Management LLC, State Street Corp, Massachusetts Financial Services Co. MA, Cubist Systematic Strategies LLC, and Engineers Gate Manager LP. Company insiders that have sold CONMED company stock in the last year include Brian Concannon, Daniel Jonas, John Jed Kennedy, Johonna Marie Pelletier, Peter K Shagory, Stanley W Peters III, Terence M Berge, and Wilfredo Ruiz-Caban.
View insider buying and selling activity for CONMED
.

Which institutional investors are buying CONMED stock?

CNMD stock was purchased by a variety of institutional investors in the last quarter, including Earnest Partners LLC, New York State Common Retirement Fund, AXA S.A., BNP PARIBAS ASSET MANAGEMENT Holding S.A., Champlain Investment Partners LLC, Segall Bryant & Hamill LLC, ExodusPoint Capital Management LP, and Penn Capital Management Co. Inc..
View insider buying and selling activity for CONMED
.

How do I buy shares of CONMED?

Shares of CNMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CONMED's stock price today?

One share of CNMD stock can currently be purchased for approximately $105.97.

How big of a company is CONMED?

CONMED has a market capitalization of $3.03 billion and generates $955.10 million in revenue each year. The medical technology company earns $28.62 million in net income (profit) each year or $2.64 on an earnings per share basis. CONMED employs 3,300 workers across the globe.

What is CONMED's official website?

The official website for CONMED is www.conmed.com.

How can I contact CONMED?

CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The medical technology company can be reached via phone at 315-797-8375.

This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.